| | | | |
CUSIP No. 47012E106 | | SCHEDULE 13D/A | | PAGE 6 OF 8 PAGES |
This Amendment No. 8 amends the Schedule 13D filed with the Securities and Exchange Commission (the “SEC”), on October 15, 2012, by California Capital Z, LLC, a California limited liability company (“California Capital”), and Dr. Patrick Soon-Shiong with respect to the common stock, par value $0.001 per share (“Common Stock”), of JAKKS Pacific, Inc., a Delaware corporation (the “Company”), as amended by (i) Amendment No. 1 thereto, filed with the SEC on April 9, 2013, (ii) Amendment No. 2 thereto, filed with the SEC on April 10, 2013, (iii) Amendment No. 3 thereto, filed with the SEC on July 15, 2013, (iv) Amendment No. 4 thereto, filed with the SEC on July 22, 2013, (v) Amendment No. 5 thereto, filed with the SEC on November 25, 2015, (vi) Amendment No. 6 thereto, filed with the SEC on March 4, 2016 and (vii) Amendment No. 7 thereto, filed with the SEC on July 26, 2016. The filing of any amendment to this Schedule 13D (including the filing of this Amendment No. 8) shall not be construed to be an admission that a material change has occurred in the facts set forth in this Schedule 13D or that such amendment is required under Rule13d-2 of the Securities Exchange Act of 1934, as amended.
This is the final amendment to this Schedule 13D and an exit filing for the Reporting Persons.
ITEM 5. | INTEREST IN SECURITIES OF THE ISSUER. |
Items 5(a) and 5(b) of this Schedule 13D are hereby amended and restated as follows:
| (a)-(b) | The responses to Items7-13 on the cover pages are incorporated by reference herein. |
Item 5(c) of this Schedule 13D is hereby amended to include the following information:
| (c) | On December 30, 2019, Dr. Soon-Shiong and California Capital sold 239,622 shares of Common Stock and 2,261,054 shares of Common Stock, respectively, for a price of $0.99 per share in a privately negotiated transaction. |
Item 5(e) of this Schedule 13D is hereby amended to include the following information:
| (e) | On December 30, 2019, as a result of the transactions described in Item 5(c) above, the Reporting Persons ceased to be a beneficial owner of more than 5% of the Common Stock. |